222 related articles for article (PubMed ID: 36190948)
1. A pan-cancer analysis of matrisome proteins reveals CTHRC1 and a related network as major ECM regulators across cancers.
Harikrishnan K; Prabhu SS; Balasubramanian N
PLoS One; 2022; 17(10):e0270063. PubMed ID: 36190948
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of the Genomic Alterations and Mutations of the Matrisome.
Izzi V; Davis MN; Naba A
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722287
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Associated Stromal Fibroblast-Derived Transcriptomes Predict Poor Clinical Outcomes and Immunosuppression in Colon Cancer.
Wang J; Akter R; Shahriar MF; Uddin MN
Pathol Oncol Res; 2022; 28():1610350. PubMed ID: 35991839
[No Abstract] [Full Text] [Related]
4. Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.
Nolan J; Mahdi AF; Dunne CP; Kiely PA
Gene; 2020 Nov; 761():145024. PubMed ID: 32755659
[TBL] [Abstract][Full Text] [Related]
5. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.
Yu C; You M; Zhang P; Zhang S; Yin Y; Zhang X
Cancer Med; 2021 Jul; 10(13):4629-4643. PubMed ID: 34121340
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
7. The cancer matrisome: From comprehensive characterization to biomarker discovery.
Socovich AM; Naba A
Semin Cell Dev Biol; 2019 May; 89():157-166. PubMed ID: 29964200
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer.
Kääriäinen A; Pesola V; Dittmann A; Kontio J; Koivunen J; Pihlajaniemi T; Izzi V
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266472
[TBL] [Abstract][Full Text] [Related]
9. CTHRC1 Induces Pancreatic Stellate Cells (PSCs) into Myofibroblast-like Cancer-Associated Fibroblasts (myCAFs).
Kang MK; Jiang F; Kim YJ; Ryu K; Masamune A; Hamada S; Park YY; Koh SS
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444482
[No Abstract] [Full Text] [Related]
10. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers.
Tang L; Dai DL; Su M; Martinka M; Li G; Zhou Y
Clin Cancer Res; 2006 Jun; 12(12):3716-22. PubMed ID: 16778098
[TBL] [Abstract][Full Text] [Related]
11. Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.
Tomko LA; Hill RC; Barrett A; Szulczewski JM; Conklin MW; Eliceiri KW; Keely PJ; Hansen KC; Ponik SM
Sci Rep; 2018 Aug; 8(1):12941. PubMed ID: 30154546
[TBL] [Abstract][Full Text] [Related]
12. Systematic Analysis of Actively Transcribed Core Matrisome Genes Across Tissues and Cell Phenotypes.
Tellman TV; Dede M; Aggarwal VA; Salmon D; Naba A; Farach-Carson MC
Matrix Biol; 2022 Aug; 111():95-107. PubMed ID: 35714875
[TBL] [Abstract][Full Text] [Related]
13. The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions.
Nauroy P; Hughes S; Naba A; Ruggiero F
Matrix Biol; 2018 Jan; 65():5-13. PubMed ID: 28739138
[TBL] [Abstract][Full Text] [Related]
14. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
15. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
[TBL] [Abstract][Full Text] [Related]
17. Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.
Kharaishvili G; Cizkova M; Bouchalova K; Mgebrishvili G; Kolar Z; Bouchal J
J Clin Pathol; 2011 Nov; 64(11):977-82. PubMed ID: 21742751
[TBL] [Abstract][Full Text] [Related]
18. Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features.
Kim JH; Baek TH; Yim HS; Kim KH; Jeong SH; Kang HB; Oh SS; Lee HG; Kim JW; Kim KD
Pathol Oncol Res; 2013 Oct; 19(4):731-7. PubMed ID: 23658133
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
20. ABERRANT EXPRESSION OF COL14A1, CELRS3, and CTHRC1 IN BREAST CANCER СELLS.
Malvia S; Chintamani C; Sarin R; Dubey US; Saxena S; Bagadi SAR
Exp Oncol; 2023 Jun; 45(1):28-43. PubMed ID: 37417284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
